Rachel Humphrey: What cancer immunologists are doing about COVID-19

Overview

What are physicians and scientists seeing in their COVID-19-infected patients and in their own personal scientific explorations? What are the ongoing hypotheses that drive the emerging clinical studies, and what can we say about the rapid evolution of medicine, in light of their ongoing work? Rachel Humphrey, shares her insights.

Rachel is a medical oncologist, who is currently serving as Head of Research and Development for TIO Bioventures. The webinar is moderated by Miriam Merad, Vice-President of the IUIS.

Speakers

Miriam Merad
Moderator

Miriam Merad is Vice-President of the IUIS.

Webinar Details

Categories: COVID-19

More Webinars

Anita McElray: Mapping human immune responses to Ebola virus infection provides insight into viral pathogenesis

Fabrizio De Benedetti: Hyperinflammation: hemophagocytic lymphohistiocytosis and macrophage activation syndrome

Claudia Mauri: Regulatory B cells and gut-microbiota: an intricate acting balance in autoimmunity

Qian Zhang: Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Antonio Lanzavecchia: Immunology taught by Plasmodium falciparum

Eric Viver: Harnessing innate immunity in cancer therapy and beyond

Pamela Ohashi: Immunoregulation and the tumor microenvironment

Adrian Hayday: Seeking correlates of protection and correlates of pathology in Covid-19 patients

Michael Reth: Ramos B cell engineering for the evaluation of the humoral anti-SARS-C